Magnetic resonance image-based brain age as a discriminator of dementia conversion in patients with amyloid-negative amnestic mild cognitive impairment

Sci Rep. 2023 Dec 18;13(1):22467. doi: 10.1038/s41598-023-49465-8.

Abstract

Patients with amyloid-negative amnestic mild cognitive impairment (MCI) have a conversion rate of approximately 10% to dementia within 2 years. We aimed to investigate whether brain age is an important factor in predicting conversion to dementia in patients with amyloid-negative amnestic MCI. We conducted a retrospective cohort study of patients with amyloid-negative amnestic MCI. All participants underwent detailed neuropsychological evaluation, brain magnetic resonance imaging (MRI), and [18F]-florbetaben positron emission tomography. Brain age was determined by the volumetric assessment of 12 distinct brain regions using an automatic segmentation software. During the follow-up period, 38% of the patients converted from amnestic MCI to dementia. Further, 73% of patients had a brain age greater than their actual chronological age. When defining 'survival' as the non-conversion of MCI to dementia, these groups differed significantly in survival probability (p = 0.036). The low-educated female group with a brain age greater than their actual age had the lowest survival rate among all groups. Our findings suggest that the MRI-based brain age used in this study can contribute to predicting conversion to dementia in patients with amyloid-negative amnestic MCI.

MeSH terms

  • Alzheimer Disease* / pathology
  • Amyloid
  • Brain / diagnostic imaging
  • Brain / pathology
  • Cognitive Dysfunction* / pathology
  • Dementia* / diagnostic imaging
  • Dementia* / pathology
  • Disease Progression
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Neuropsychological Tests
  • Positron-Emission Tomography
  • Retrospective Studies
  • Tomography, X-Ray Computed

Substances

  • Amyloid